Abstract
Aspartylglycosaminuria (AGU) is a lysosomal storage disorder of glycoprotein degradation characterized by severe mental retardation and connective tissue alterations. We have previously described low collagen production in skin fibroblast cultures from AGU patients. In the present work we showed that the urinary excretion of hydroxyproline (total, non-dialysable and free hydroxyproline as indicators of collagen metabolism) was reduced in young AGU patients in comparison with age-matched controls. In adult patients no significant difference was detected. The results support the view that reduced collagen production is associated with the connective tissue abnormalities in this disorder.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Aula, P., Autio, S., Raivio, K. O. and Rapola, J. Aspartylglycosaminuria. In Durand, P. and O'Brien, J. S. (eds.)Genetic Errors of Glycoprotein Metabolism, Edi-Ermes, Milano, 1982, pp. 123–152
Autio, S. Aspartylglycosaminuria. Analysis of thirty-four patients.J. Ment. Def. Res. Monogr. Ser. I (1972) 1–93
Camara, A. A., Arn, K. D., Reimer, A. and Newburgh, L. H. The twenty-four hour endogenous creatinine clearance as a measure of the functional state of the kidney.J. Lab. Clin. Med. 37 (1951) 743–748
Donaldson, C. L., Hulley, S. B., Vogel, J. M., Hattner, R. S., Bayers, J. H. and MacMillan, D. E. Effect of prolonged bed rest on bone mineral metabolism.Metabolism 19 (1970) 1071–1075
Halse, J. and Gordeladze, J. O. Total and non-dialyzable urinary hydroxyproline in acromegalics and control subjects.Acta Endocrinol. 96 (1981) 451–457
Hodgkinson, A. and Thompson, T. Measurement of the fasting urinary hydroxyproline: creatinine ratio on normal adults and its variation with age and sex.J. Clin. Pathol. 35 (1982) 807–811
Kivirikko, K. I. Urinary excretion of hydroxyproline in health and disease.Int. Rev. Conn. Tissue Res. 5 (1970) 93–163
Kivirikko, K. I., Laitinen, O. and Prockop, D. J. Modifications of a specific assay for hydroxyproline in urine.Anal. Biochem. 19 (1967) 249–255
Laitinen, O. Clinical applications of urinary hydroxyproline determination.Acta Med. Scand. Suppl. 577 (1974) 1–57
Laitinen, O., Nikkilä, E. A. and Kivirikko, K. I. Hydroxyproline in serum and urine. Normal values and clinical significance.Acta Med. Scand. 179 (1966) 275–284
Mundy, A. R. Urinary hydroxyproline excretion in carcinoma of the prostate. A comparison of 4 different modes of assessment and its role as a marker.Br. J. Urol. 51 (1979) 570–574
Näntö-Salonen, K., Pellinienis, L. J., Autio, S., Vivirnäte, T., Rapola, J. and Penttinen, R. Abnormal collagen fibrils in aspartylglycosaminuria: altered dermal ultrastructure in a glycoprotein storage disorder.Lab. Invest. (in press)
Näntö-Salonen, K. and Penttinen, R. Metabolism of collagen in aspartylglycosaminuria: decreased synthesis by cultured fibroblasts.J. Inher. Metab. Dis. 5 (1982) 197–203
Skogland, L. B., Miller, J. A. A., Skottner, A. and Fryklund, L. Serum somatomedin A and non-dialyzable urinary hydroxyproline in girls with idiopathic scoliosis.Acta Orthop. Scand. 52 (1981) 307–313
Smith, M., Ansell, B. M. and Bywakers, E. G. Urinary hydroxyproline excretion in patients with juvenile rheumatoid arthritis with and without corticosteroid therapy.J. Pediatr. 73 (1968) 875–881
Tolstoshev, P., Berg, R. A., Rennard, S. I., Bradley, K. H., Trapnell, B. C. and Chrystal, R. G. Procollagen production and procollagen messenger RNA levels and activity in human lung fibroblasts during periods of rapid and stationary growth.J. Biol. Chem. 256 (1981) 3135–3140
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Näntö-Salonen, K., Autio, S., Härö, E. et al. Metabolism of collagen in aspartylglycosaminuria: Urinary excretion of hydroxyproline. J Inherit Metab Dis 7, 117–121 (1984). https://doi.org/10.1007/BF01801767
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01801767